-
More than 400 dead in DR Congo's spreading Ebola outbreak
-
Albanian clashes as protest over Trump-linked resort boils over
-
Hot spell roasts eastern US as holiday weekend approaches
-
Desire key to Pogacar dominance, says former Tour king Froome
-
Superb Swiatek storms into Wimbledon last 32, Zverev waits
-
Rescuers dig out Venezuelan man eight days after quakes
-
Russian strikes kill 21 in biggest ever attack on Kyiv, mayor says
-
Anderson closes in on record Man City move
-
Swiatek sees off Pliskova to race into Wimbledon third round
-
England change five for South Africa Test
-
Dollar down, stocks shine after disappointing US jobs data
-
Lock Alemanno to make 100th Pumas appearance against Scotland
-
US job growth slows, posing questions for Trump before midterms
-
US posts weaker-than-expected job growth in June
-
Chanel eyes menswear with Charvet shirtmaker takeover
-
UK PM says 'deeply sorry' for decades of forced adoptions
-
Chanel eyes menswear with Charvet shirtmaker takevoer
-
Almost 1.2 mn apply for Spain's migrant regularisation
-
'I grabbed my child': Kyiv residents face devastation of biggest Russian barrage of war
-
Ukrainian state ordered Nord Stream sabotage: German prosecutors
-
Former top jockey Dettori breaks ribs in car crash
-
Swiatek, Zverev aiming to lay down Wimbledon markers
-
Rees-Zammit returns to wing as Wales face Fiji
-
German ruling coalition agrees on major reform package
-
Renovations on historic Paris Opera house extended by three years
-
European stocks climb after Asia rout
-
Thailand denies viral claim Macron knelt before king
-
Former Arsenal, Spain midfielder Cazorla retires
-
Spain, Portugal eye World Cup last 16
-
German drone maker raises $1.2 bn as investors pile into defence
-
Russian strikes kill 17 in biggest ever attack on Kyiv, mayor says
-
French scramble to find air conditioners before next heatwave
-
Uruguay veteran Cavani quits Boca Juniors
-
Japan deploys bear cameras in moutains as attacks surge
-
West Ham's Fernandes joins Spurs
-
Germany's Infineon opens major chip plant as EU seeks tech autonomy
-
Bones of contention: More research needed on 'd'Artagnan corpse'
-
Biggest ever Russian barrage on Kyiv kills at least 13
-
Coffee with a view: tourists flock to Starbucks overlooking North Korea
-
EU top court upholds record 4.1 bn euro Google fine
-
German coalition agrees on reform package in key breakthrough
-
Italy name two debutants to face Japan in Nations Championship opener
-
France recall record try scorer Penaud for All Blacks Test
-
Wallabies' Schmidt rules out another coaching job
-
Seoul's Kospi tanks as Asia tech firms suffer another blow
-
India asks Meta to hold WhatsApp username rollout over fraud fears
-
'Outstanding' Love to start at fly-half for All Blacks against France
-
Deadly Russian barrage on Kyiv kills at least 13
-
Campbell back from four years in Wallabies wilderness to face Ireland
-
Next indirect US-Iran talks after Khamenei funeral: mediators
Trump announces departure of food and drug regulation chief
President Donald Trump said Tuesday his US Food and Drug Administration chief, Marty Makary, is leaving his post, a departure that follows weeks of political tumult at the powerful agency.
During his tenure atop the sprawling body responsible for overseeing vaccines, medicine and food, Makary managed to upset figures across industry, politics and public health over a range of issues, and most recently faced pressure from the Republican president to sign off on fruit-flavored vapes.
"Marty is a terrific guy, but he's going to go on, and he's going to lead a good life," Trump said, speaking to journalists who pressed him on the reported resignation that comes after weeks of rumors that the president planned to fire his FDA commissioner.
Makary, a surgeon and former Fox News contributor, made waves during the Covid-19 pandemic as an outspoken critic of the medical establishment and the health measures of the time.
He took over the FDA promising reform. He leaves just over a year later, facing criticism from all angles, including from pharmaceutical executives, tobacco lobbyists, and anti-abortion activists.
Conservatives against the abortion pill mifepristone accuse Makary of taking too long to complete and issue a review of the drug that's been FDA-approved for 25 years, but which they continue to target.
The Trump administration meanwhile forged ahead with a policy allowing for the sale of flavored e-cigarettes despite resistance from Makary, who had voiced concern over the appeal of the vapes to youth.
Many pharmaceutical executives said Makary's initiatives to shake up the drug review process had only created more problems.
And public health leaders accused him of catering to anti-vaccine activists after the FDA put out an unsupported memo claiming deaths linked to the Covid-19 vaccine.
It's the latest in a string of shake-ups at the health department overseen by noted vaccine skeptic Robert F. Kennedy Jr, with figures seen as more conventional put forth as nominees to be surgeon general as well as helm the Centers for Disease Control and Prevention.
Y.Nakamura--AMWN